Chargement en cours...

Oral platelet glycoprotein IIb/IIIa receptor inhibitors—part I

With the central importance of antiplatelet therapy in patients with coronary artery disease and the numerous positive trials with glycoprotein (GP) IIb/IIIa inhibitors given intravenously, it was hoped that one could extend the benefit of IIb/IIIa inhibition to long‐term treatment. Although the hyp...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Cardiol
Auteur principal: Cannon, Christopher P.
Format: Artigo
Langue:Inglês
Publié: Wiley Periodicals, Inc. 2006
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6654758/
https://ncbi.nlm.nih.gov/pubmed/12918637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4950260803
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!